Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma

Journal article

Open access

Peer reviewed

Cell communication and signaling, Vol.17(1), pp.127-127

16/10/2019

PMCID: PMC6794763

PMID: 31619257

Abstract

hepatocellular carcinoma

Phloretin

SHP-1

Sorafenib

STAT3

url

https://doi.org/10.1186/s12964-019-0430-7View

Published (Version of record) Open

1 Record Views

Title: Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma
Creators - without role: Sarita Saraswati - King Saud University
Abdulqader Alhaider - King Saud University
Abdelgalil Mohamed Abdelgadir - King Saud bin Abdulaziz University for Health Sciences
Pooja Tanwer - Indian Institute of Technology Delhi
Hesham M. Korashy - Qatar University
Publication Details: Cell communication and signaling, Vol.17(1), pp.127-127
Publisher: BioMed Central
Grant note: ;
Identifiers: 9921374008331
Academic Unit: King Saud Bin Abdulaziz University for Health Sciences; King Saud University
Language: English
Resource Type: Journal article